Showing 1 - 13 results of 13 for search 'Moore, Peter', query time: 0.06s
Refine Results
-
1
-
2
-
3
A fundamental investigation of surface-induced skin irritation by Moore, Peter Nathaniel, 1974-
Published 2005
Thesis -
4
-
5
-
6
-
7
THE ATLAS OF THE LIVING WORLD / by 247269 Attenborough, David, Whitfield, Philip, Moore, Peter D., Cox, Barry
Published 1989 -
8
FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes <it>in vivo </it>during the asymptomatic phase of infection by Murphy Brian, Vapniarsky Natasha, Hillman Chad, Castillo Diego, McDonnel Samantha, Moore Peter, Luciw Paul A, Sparger Ellen E
Published 2012-02-01
Article -
9
Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families by Robert-Tissot Céline, Rüegger Vera L, Cattori Valentino, Meli Marina L, Riond Barbara, Moore Peter F, Engels Monika, Franchini Marco, Hofmann-Lehmann Regina, Lutz Hans
Published 2012-08-01
Article -
10
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis by Choudhury, Rashikh, Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Talmor, Daniel S., Nydam, Trevor L., Yaffe, Michael B.
Published 2020
Article -
11
Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series by Wang, Janice, Hajizadeh, Negin, Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Veress, Livia A., Yaffe, Michael B., Moore, Hunter B., Barrett, Christopher D.
Published 2020
Article -
12
STudy of Alteplase for Respiratory failure in SARS‐Cov2/COVID‐19: Study Design of the Phase IIa STARS Trial by Moore, Hunter B., Barrett, Christopher D, Moore, Ernest E., Jhunjhnuwala, Rashi, McIntyre, Robert C., Moore, Peter K, Wang, Janice, Hajizadeh, Negin, Talmor, Daniel S., Sauaia, Angela, Yaffe, Michael B
Published 2020
Article -
13
Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review by Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K, Burke, John, Hua, Fei, Apgar, Joshua, Talmor, Daniel S., Sauaia, Angela, Liptzin, Deborah R., Veress, Livia A., Yaffe, Michael B.
Published 2020
Article